311 related articles for article (PubMed ID: 27587275)
1. Classification of breast cancer patients using somatic mutation profiles and machine learning approaches.
Vural S; Wang X; Guda C
BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):62. PubMed ID: 27587275
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients.
Zhang J; Abrams Z; Parvin JD; Huang K
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):513. PubMed ID: 27556157
[TBL] [Abstract][Full Text] [Related]
3. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
4. pyCancerSig: subclassifying human cancer with comprehensive single nucleotide, structural and microsatellite mutational signature deconstruction from whole genome sequencing.
Thutkawkorapin J; Eisfeldt J; Tham E; Nilsson D
BMC Bioinformatics; 2020 Apr; 21(1):128. PubMed ID: 32245405
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
[TBL] [Abstract][Full Text] [Related]
6. Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.
Li Y; Wang X; Vural S; Mishra NK; Cowan KH; Guda C
PLoS One; 2015; 10(3):e0119383. PubMed ID: 25803781
[TBL] [Abstract][Full Text] [Related]
7. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
Wang L; Li F; Sheng J; Wong ST
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
[TBL] [Abstract][Full Text] [Related]
8. Cancer classification and pathway discovery using non-negative matrix factorization.
Zeng Z; Vo AH; Mao C; Clare SE; Khan SA; Luo Y
J Biomed Inform; 2019 Aug; 96():103247. PubMed ID: 31271844
[TBL] [Abstract][Full Text] [Related]
9. Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.
Roy S; Kumar R; Mittal V; Gupta D
Sci Rep; 2020 Mar; 10(1):4113. PubMed ID: 32139710
[TBL] [Abstract][Full Text] [Related]
10. Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data.
Ding J; Bashashati A; Roth A; Oloumi A; Tse K; Zeng T; Haffari G; Hirst M; Marra MA; Condon A; Aparicio S; Shah SP
Bioinformatics; 2012 Jan; 28(2):167-75. PubMed ID: 22084253
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
12. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
[TBL] [Abstract][Full Text] [Related]
13. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
[TBL] [Abstract][Full Text] [Related]
14. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic pathways in hereditary and sporadic breast cancer.
Kenemans P; Verstraeten RA; Verheijen RH
Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
[TBL] [Abstract][Full Text] [Related]
16. Mutation-Attention (MuAt): deep representation learning of somatic mutations for tumour typing and subtyping.
Sanjaya P; Maljanen K; Katainen R; Waszak SM; ; Aaltonen LA; Stegle O; Korbel JO; Pitkänen E
Genome Med; 2023 Jul; 15(1):47. PubMed ID: 37420249
[TBL] [Abstract][Full Text] [Related]
17. The method for breast cancer grade prediction and pathway analysis based on improved multiple kernel learning.
Song T; Wang Y; Du W; Cao S; Tian Y; Liang Y
J Bioinform Comput Biol; 2017 Feb; 15(1):1650037. PubMed ID: 27899048
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.
Langerød A; Zhao H; Borgan Ø; Nesland JM; Bukholm IR; Ikdahl T; Kåresen R; Børresen-Dale AL; Jeffrey SS
Breast Cancer Res; 2007; 9(3):R30. PubMed ID: 17504517
[TBL] [Abstract][Full Text] [Related]
19. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
[TBL] [Abstract][Full Text] [Related]
20. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]